PAX5-AUTS2: A recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia

Leukemia Research

Volumn 36, Issue 8, 2012, Pages

  Denk, Dagmar ^a   Nebral, Karin ^a   Bradtke, Jutta ^b   Pass, Gertrud ^c   Möricke, Anja ^d   Attarbaschi, Andishe ^e   Strehl, Sabine ^a  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c Labdia Labordiagnostik   (Austria)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Childhood acute lymphoblastic leukemia; Fusion transcript; PAX5 AUTS2

Indexed keywords

PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; CAUSE OF DEATH; CELL INFILTRATION; CELL STRUCTURE; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; INFANT; INFECTION; KARYOTYPE; LEUKEMIA REMISSION; MALE; OUTCOME ASSESSMENT; PAX5 AUTS2 GENE; PRIORITY JOURNAL; RELAPSE; TREATMENT FAILURE;

AGE OF ONSET; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; GENE FREQUENCY; HUMANS; INFANT; MALE; ONCOGENE PROTEINS, FUSION; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSLOCATION, GENETIC;

EID: 84862541658     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.04.015     Document Type: Article

References (8)

1. Medvedovic J., Ebert A., Tagoh H., Busslinger M. Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol 2011, 111:179-206.
2. Familiades J., Bousquet M., Lafage-Pochitaloff M., Bene M.C., Beldjord K., De Vos J., et al. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study. Leukemia 2009, 23(11):1989-1998.
3. Nebral K., Denk D., Attarbaschi A., Konig M., Mann G., Haas O.A., et al. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia. Leukemia 2009, 23(1):134-143.
4. Coyaud E., Struski S., Prade N., Familiades J., Eichner R., Quelen C., et al. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study. Blood 2010, 115(15):3089-3097.
5. Pichler H., Moricke A., Mann G., Teigler-Schlegel A., Niggli F., Nebral K., et al. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Munster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. Br J Haematol 2010, 149(1):93-100.
6. Kawamata N., Ogawa S., Zimmermann M., Niebuhr B., Stocking C., Sanada M., et al. Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Proc Natl Acad Sci USA 2008, 105(33):11921-11926.
7. Coyaud E., Struski S., Dastugue N., Brousset P., Broccardo C., Bradtke J. PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia. Leukemia Res 2010, 34(12):e323-e325.
8. Bedogni F., Hodge R.D., Nelson B.R., Frederick E.A., Shiba N., Daza R.A., et al. Autism susceptibility candidate 2 (Auts2) encodes a nuclear protein expressed in developing brain regions implicated in autism neuropathology. Gene Expr Patterns 2010, 10(1):9-15.